海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Efficay of fibrinogen in liver transplantation
- Liver transplantation is a special risk situation for acute and severe bleeding determined by the complexity of the surgical procedure and by the alteration of haemostasis and coagulation factors, especially fibrinogen, present in the patient affected by a terminal hepatopathy. MedDRA version: 20.0 Level: LLT Classification code 10024716 Term: Liver transplantation System Organ Class: 100000004865 ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Spain
- 2018-08-07
Authorised
- A new therapeutic approach to prevent acute complications in type 2 diabetes: The effect of the combination of the GLP-1 Analog Liraglutide and Insulin LEvemir® against the cOnventional insulin therapy: GALILEO
- diabetes mellitus type 2, inadequate metabolic control, indication for insulin therapy myocardial lipid accumulation and left-ventricular function, retinal changes, microabluminuria, beta-cell-function, endothelial dysfunction MedDRA version: 14.1 Level: PT Classification code 10012607 Term: Diabetes mellitus inadequate control System Organ Class: 10027433 - Metabolism and nutrition disorders MedDRA version: 14.1 Level: PT Classification code 10012689 Term: Diabetic retinopathy System Organ Class: 10015919 - Eye disorders MedDRA version: 14.1 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders MedDRA version: 14.1 Level: HLT Classification code 10012654 Term: Diabetic complications cardiovascular System Organ Class: 10014698 - Endocrine disorders MedDRA version: 14.1 Level: PT Classification code 10012647 Term: Diabetic cardiomyopathy System Organ Class: 10007541 - Cardiac disorders MedDRA version: 14.1 Level: HLT Classification code 10012658 Term: Diabetic complications renal System Organ Class: 10014698 - Endocrine disorders MedDRA version: 14.1 Level: HLT Classification code 10012657 Term: Diabetic complications ophthalmic System Organ Class: 10014698 - Endocrine disorders MedDRA version: 14.1 Level: PT Classification code 10054044 Term: Diabetic microangiopathy System Organ Class: 10047065 - Vascular disorders MedDRA version: 14.1 Level: HLGT Classification code 10012653 Term: Diabetic complications System Organ Class: 10014698 - Endocrine disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Austria
- 2012-04-17
Authorised
- Assessment of aspirin response in patients with Type 1 diabetes mellitus: a pilot study
- type 1 diabetes MedDRA version: 14.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
- Italy
- 2012-03-13
Authorised
- Clinical trial to assess the efficacy of pancreatic enzyme replacement therapy in patients with pancreatic exocrine insufficiency secondary to type 1 diabetes mellitus.
- Patients with pancreatic exocrine insufficiency (PEI) secondary to type 1 diabetes mellitus (DM);Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Spain
- 2013-09-16
Authorised
- Effect of INtervention with DMR, GLP-1 and lifestyle intensification -in Subjects with insulin dePendent type 2 diabetes- on Insulin Requirement and mEtabolic parameters
- Type 2 diabetes mellitus;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
- Netherlands
- 2017-06-27
Authorised
- Effects of Omega-3-Fatty Acids on Arterial Endothelial Function and Intima Media Thickness in Children with Insulin-Dependent Diabetes Mellitus
- Diabetes mellitus type 1 in children
- Sweden
- 2006-09-07
Authorised
- A Phase III, Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of 50 mg Oral Dosing with the Neurokinin-1 Receptor Antagonist GW679769 for the Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
- Postoperative Nausea and Vomiting (PONV)
- Germany, Hungary, Ireland, United Kingdom
- 2006-02-21
Authorised
- Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients with Selected CD38+ Hematological Malignancies
- Haematological malignancy MedDRA version: 20.0 Level: PT Classification code 10066476 Term: Haematological malignancy System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Austria, Belgium, Brazil, Chile, Colombia, Finland, Greece, Israel, Italy, Mexico, Peru, Russian Federation, Spain, Turkey, Ukraine, United Kingdom, United States
- 2016-11-04
Authorised
- Comparison of the Safety and Efficacy of HOE901-U300 with Lantus in Children and Adolescents with Type 1 Diabetes Mellitus
- Type 1 diabetes mellitus br>MedDRA version: 19.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Argentina, Brazil, Canada, Chile, Czech Republic, France, Germany, Hungary, Israel, Italy, Japan, Latvia, Mexico, Poland, Romania, Russian Federation, Spain, United Kingdom, United States
- 2016-03-01
Authorised
- A Clinical Trial to Compare the effectiveness and safety of Gan & Lee Pharmaceuticals Insulin Glargine Injection to Lantus® (Insulin Glargine Injection) in Adults with Type 1 Diabetes Mellitus
- Type 1 diabetes mellitus br>MedDRA version: 20.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Czech Republic, Germany, Hungary, Poland, Russian Federation, Spain, Ukraine, United States
- 2017-12-13
